BioNTech SE ADR rises Friday, outperforms market

This post was originally published on this site

© Terrence Horan


The BioNTech SE ADR BNTX advanced 7.15% to $100.39 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.55% to 3,824.68 and the Dow Jones Industrial Average DJIA rising 0.18% to 31,097.97. This was the ADR’s fifth consecutive day of gains. BioNTech SE ADR closed $30.61 short of its 52-week high ($131.00), which the company achieved on December 11th.

The ADR outperformed some of its competitors Friday, as AbbVie Inc. ABBV rose 0.52% to $107.27 and Amgen Inc. AMGN rose 1.91% to $238.49. Trading volume (4.0 M) remained 447,263 below its 50-day average volume of 4.4 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading